ARCT FY 2022 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$217M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$206M+1564.8% YoY

Gross Profit

$206M100.0% margin

Operating Income

$12M5.9% margin

Net Income

$9M4.5% margin

EPS (Diluted)

$0.35

Cash Flow

Operating Cash Flow

$32M

Free Cash Flow

$24M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$450M

Total Liabilities

$180M

Stockholders' Equity

$270M

Cash & Equivalents

$392M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$206M	$12M	+1564.8%
Gross Profit	$206M	$12M	+1564.8%
Operating Income	$12M	-$203M	+106.0%
Net Income	$9M	-$204M	+104.6%